Adjudicating Mild Cognitive Impairment Due to Alzheimer’s Disease as a Novel Endpoint Event in the TOMMORROW Prevention Clinical Trial

Lon S. Schneider, D. A. Bennett, M. R. Farlow, E. R. Peskind, M. A. Raskind, M. Sano, Y. Stern, S. Haneline, K. A. Welsh-Bohmer, J. O’Neil, R. Walter, S. Maresca, M. Culp, R. Alexander, A. M. Saunders, D. K. Burns, C. Chiang

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Adjudicating Mild Cognitive Impairment Due to Alzheimer’s Disease as a Novel Endpoint Event in the TOMMORROW Prevention Clinical Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences